ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,239.20
0.04%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36577
0.12%
Bitcoin
69,910.33
-0.32%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) News

TBPH

Theravance Biopharma (TBPH)

Theravance Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TBPH
DateTimeSourceHeadlineSymbolCompany
05/15/20245:26AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBPHTheravance Biopharma Inc
05/13/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
05/13/20243:05PMPR Newswire (US)Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
05/10/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/10/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/10/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/10/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
05/09/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
05/09/20245:00AMPR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
04/29/20245:00AMPR Newswire (US)Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:TBPHTheravance Biopharma Inc
04/10/20245:00AMPR Newswire (US)Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024NASDAQ:TBPHTheravance Biopharma Inc
02/26/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
02/26/20243:05PMPR Newswire (US)Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
02/22/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/22/20247:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/22/20247:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/22/20247:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/22/20247:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/22/20245:00AMPR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
02/16/20247:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
02/14/20243:00PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TBPHTheravance Biopharma Inc
02/14/20245:00AMPR Newswire (US)Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:TBPHTheravance Biopharma Inc
01/16/20245:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
01/05/20245:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
01/05/20245:00AMPR Newswire (US)Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:TBPHTheravance Biopharma Inc
12/28/20235:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
12/26/20235:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
12/26/20235:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
12/21/20234:10PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TBPHTheravance Biopharma Inc
12/21/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:TBPH

Your Recent History

USOTC
QEDN
QED Connect (PK)
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
LWLG
Lightwave Logic
USOTC
DPLS
DarkPulse (PK)
USOTC
CNNA
Cann American (CE)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
TLRY
Tilray Brands
USOTC
SONGD
Music Licensing (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved